These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11989900)

  • 21. Do we make progress in elderly patients with metastatic colorectal cancer?
    Glimelius B; Pfeiffer P
    Acta Oncol; 2018 Nov; 57(11):1422-1426. PubMed ID: 30384805
    [No Abstract]   [Full Text] [Related]  

  • 22. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
    Klautke G; Fietkau R
    Strahlenther Onkol; 2002 Mar; 178(3):163-4. PubMed ID: 11962194
    [No Abstract]   [Full Text] [Related]  

  • 23. Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer).
    Labianca R; Pancera G; Aitini E; Barni S; Beretta A; Beretta GD; Cesana B; Comella G; Cozzaglio L; Cristoni M
    Ann Oncol; 1991 Oct; 2(9):673-9. PubMed ID: 1742223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy.
    Huang MY; Huang ML; Chen MJ; Lu CY; Chen CF; Tsai PC; Chuang SC; Hou MF; Lin SR; Wang JY
    Pharmacogenet Genomics; 2011 Jan; 21(1):18-25. PubMed ID: 21057378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
    Allegra C; George T; Yothers G
    J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical management of colorectal carcinomas.
    Verschraegen CF; Pazdur R
    Tumori; 1994 Feb; 80(1):1-11. PubMed ID: 8191590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irinotecan and mismatch repair deficiency.
    Power DG; Feilchenfeldt J
    Ann Oncol; 2010 Feb; 21(2):432-433. PubMed ID: 19940003
    [No Abstract]   [Full Text] [Related]  

  • 28. The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab.
    Simkens LHJ; Tol J; Terstappen LWMM; Teerenstra S; Punt CJA; Nagtegaal ID
    Ann Oncol; 2010 Dec; 21(12):2447-2448. PubMed ID: 21030382
    [No Abstract]   [Full Text] [Related]  

  • 29. New possibilities in chemotherapy for colorectal cancer.
    Bekradda M; Cvitkovic E
    Ann Oncol; 1999; 10 Suppl 6():105-11. PubMed ID: 10676561
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemotherapy for colorectal cancer in the elderly: Whom to treat and what to use.
    Feliu J; Sereno M; Castro JD; Belda C; Casado E; González-Barón M
    Cancer Treat Rev; 2009 May; 35(3):246-54. PubMed ID: 19345021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tegafur.uracil for treatment of colorectal cancer].
    Fujii M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():349-51. PubMed ID: 14574910
    [No Abstract]   [Full Text] [Related]  

  • 32. Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial.
    Pietrantonio F; Fucà G; Manca P; Pagani F; Raimondi A; Prisciandaro M; Randon G; Corti F; de Braud F; Cremolini C; Miceli R
    Tumori; 2021 Aug; 107(4):353-359. PubMed ID: 33021466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer.
    Punt CJ; Koopman M
    J Clin Oncol; 2008 Apr; 26(11):1907-8; author reply 1908-9. PubMed ID: 18398161
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of palliative chemotherapy in elderly patients with colorectal cancer.
    Bohle W; Pachlhofer A; Zoller WG
    Z Gastroenterol; 2019 Apr; 57(4):484-490. PubMed ID: 30965378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.
    Price TJ; Townsend AR; Khattak A
    Ann Oncol; 2010 Oct; 21(10):2121; author reply 2121-2. PubMed ID: 20860991
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab.
    Bates DO; Catalano PJ; Symonds KE; Varey AH; Ramani P; O'Dwyer PJ; Giantonio BJ; Meropol NJ; Benson AB; Harper SJ
    Clin Cancer Res; 2012 Nov; 18(22):6384-91. PubMed ID: 23104894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical Oncology: IROX as second-line therapy for metastatic colorectal cancer.
    Sobrero A
    Nat Rev Clin Oncol; 2009 May; 6(5):248-50. PubMed ID: 19390546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current perspectives in the treatment of metastatic colorectal cancer.
    Köhne CH; Folprecht G
    Ann Oncol; 2004; 15 Suppl 4():iv43-53. PubMed ID: 15477334
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.